Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by T.-Y. Kim
Phase I and Pharmacokinetic Study of Genexol-Pm, a Cremophor-Free, Polymeric Micelle-Formulated Paclitaxel, in Patients With Advanced Malignancies
Clinical Cancer Research
Cancer Research
Oncology
Combination of EGFR and MEK1/2 Inhibitor Shows Synergistic Effects by Suppressing EGFR/HER3-dependent AKT Activation in Human Gastric Cancer Cells
Molecular Cancer Therapeutics
Cancer Research
Oncology
Related publications
A Phase II Trial of Cremorphor EL-free Paclitaxel (Genexol-Pm) and Gemcitabine in Patients With Advanced Non-Small Cell Lung Cancer
Cancer Chemotherapy and Pharmacology
Cancer Research
Toxicology
Oncology
Pharmacology
A Phase I Study of Indoximod in Patients With Advanced Malignancies
Oncotarget
Oncology
Phase I, Pharmacokinetic, and Biological Study of Erlotinib in Combination With Paclitaxel and Carboplatin in Patients With Advanced Solid Tumors
Clinical Cancer Research
Cancer Research
Oncology
A Phase I and Pharmacokinetic Study of Weekly Paclitaxel and Carboplatin in Patients With Metastatic Esophageal Cancer
Clinical Cancer Research
Cancer Research
Oncology
A Phase I Study of Paclitaxel, Topotecan, Cisplatin and Filgrastim in Patients With Newly Diagnosed Advanced Ovarian Epithelial Malignancies: A Gynecologic Oncology Group Study
Gynecologic Oncology
Gynecology
Oncology
Obstetrics
A Phase I Study of Weekly Topotecan in Combination With Pemetrexed in Patients With Advanced Malignancies
Oncologist
Cancer Research
Medicine
Oncology
A Phase I Study of Napabucasin Plus Paclitaxel for Japanese Patients With Advanced/Recurrent Gastric Cancer
In Vivo
Biochemistry
Medicine
Genetics
Pharmacology
Molecular Biology
Anti-Pd-1 Monoclonal Antibody MEDI0680 in a Phase I Study of Patients With Advanced Solid Malignancies
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
A Phase I Trial of Combined Ridaforolimus and MK-2206 in Patients With Advanced Malignancies
Clinical Cancer Research
Cancer Research
Oncology
